These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9540934)

  • 1. Cost-effectiveness of routine antenatal varicella screening.
    Glantz JC; Mushlin AI
    Obstet Gynecol; 1998 Apr; 91(4):519-28. PubMed ID: 9540934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of the presumed susceptible varicella (chickenpox)-exposed gravida: a cost-effectiveness/cost-benefit analysis.
    Rouse DJ; Gardner M; Allen SJ; Goldenberg RL
    Obstet Gynecol; 1996 Jun; 87(6):932-6. PubMed ID: 8649701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention.
    McKendrick MW; Lau J; Alston S; Bremner J
    J Infect; 2007 Jul; 55(1):64-7. PubMed ID: 17418420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles.
    Pinot de Moira A; Edmunds WJ; Breuer J
    Vaccine; 2006 Feb; 24(9):1298-307. PubMed ID: 16236401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of varicella contacts in pregnancy: VZIG or vaccination?
    Troughton JA; Crealey G; Crawford V; Coyle PV
    J Clin Virol; 2009 Dec; 46(4):345-8. PubMed ID: 19828369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination.
    Hanslik T; Boëlle PY; Schwarzinger M; Carrat F; Freedberg KA; Valleron AJ; Flahault A
    Vaccine; 2003 Sep; 21(25-26):3614-22. PubMed ID: 12922090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age.
    Plans P; Costa J; Espuñes J; Plasència A; Salleras L
    BJOG; 2007 Sep; 114(9):1122-7. PubMed ID: 17666097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of serologic testing for varicella in an adolescent population.
    Ronan K; Wallace MR
    Vaccine; 2001 Sep; 19(32):4700-2. PubMed ID: 11535319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella seroprevalence among health care workers in Korea: validity of self-reported history and cost-effectiveness of prevaccination screening.
    Kang JH; Park YS; Park SY; Kim SB; Ko KP; Seo YH
    Am J Infect Control; 2014 Aug; 42(8):885-7. PubMed ID: 25087140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and economic impact of various strategies for varicella immunity screening and vaccination of health care personnel.
    Baracco GJ; Eisert S; Saavedra S; Hirsch P; Marin M; Ortega-Sanchez IR
    Am J Infect Control; 2015 Oct; 43(10):1053-60. PubMed ID: 26138999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella zoster antibody testing in the care of pregnant women exposed to varicella.
    McGregor JA; Mark S; Crawford GP; Levin MJ
    Am J Obstet Gynecol; 1987 Aug; 157(2):281-4. PubMed ID: 3039845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difficulty in determining varicella-zoster immune status in pregnant women.
    Le CT; Lipson M
    Pediatr Infect Dis J; 1989 Sep; 8(9):650-1. PubMed ID: 2552391
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost effectiveness of vaccination strategies in adults without a history of chickenpox.
    Smith KJ; Roberts MS
    Am J Med; 2000 Jun; 108(9):723-9. PubMed ID: 10924649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of chickenpox in reproductive-age women: cost-effectiveness of routine prenatal screening with postpartum vaccination of susceptibles.
    Smith WJ; Jackson LA; Watts DH; Koepsell TD
    Obstet Gynecol; 1998 Oct; 92(4 Pt 1):535-45. PubMed ID: 9764625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postpartum varicella vaccination: is the vaccine virus excreted in breast milk?
    Bohlke K; Galil K; Jackson LA; Schmid DS; Starkovich P; Loparev VN; Seward JF
    Obstet Gynecol; 2003 Nov; 102(5 Pt 1):970-7. PubMed ID: 14672472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella-zoster virus: Prevention through vaccination.
    Gnann JW
    Clin Obstet Gynecol; 2012 Jun; 55(2):560-70. PubMed ID: 22510639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella serology among school age children with a negative or uncertain history of chickenpox.
    Lieu TA; Black SB; Takahashi H; Ray P; Capra AM; Shinefield HR; Adler NE
    Pediatr Infect Dis J; 1998 Feb; 17(2):120-5. PubMed ID: 9493807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of varicella screening and vaccination in U.S. Army recruits.
    Howell MR; Lee T; Gaydos CA; Nang RN
    Mil Med; 2000 Apr; 165(4):309-15. PubMed ID: 10803008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic impact of prenatal varicella immunity among pregnant women in Alberta.
    Passi A; Plitt SS; Lai FY; Simmonds K; Charlton CL
    Vaccine; 2017 Jan; 35(4):570-576. PubMed ID: 28017427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.